DOSAGE FORMS – Page 24

E&L Failure in MDI assembly: E&L risk assessment and documentation

Symptoms of E&L failures may manifest during routine analysis, investigations, or post-production quality control checks. Key indicators of potential E&L issues include:Click to read the full article.

Cascade Impactor Setup Error after device supplier change: FDA/MHRA investigation and corrective actions

The first step in any investigation is to identify and document the symptoms or signals that prompted the need for further scrutiny. For a cascade impactor setup error after a…

Apsd Oos during method transfer: method variability vs true product failure assessment

When investigating APSD OOS results during method transfer, the first step is identifying the symptoms or signals that indicate a potential problem. Key signals might include:Click to read the full…

Delivered Dose Uniformity Failure during method transfer: device qualification and assembly controls

Understanding the trigger points for investigating delivered dose uniformity failures is paramount. Symptoms may vary but often manifest in the following ways:Click to read the full article.

DOSAGE FORMS – Complete Guide

This topic covers essential principles, best practices, and real-world applications.Click to read the full article.